Norvēģija - norvēģu - Statens legemiddelverk

dr. falk pharma gmbh - kaliumklorid / natriumklorid / natriumhydrogenkarbonat / makrogol 3350 - pulver til mikstur, oppløsning - 185 mg / 1.4 g / 715 mg / 52.5 g

Norvēģija - norvēģu - Statens legemiddelverk

astrazeneca - tamoksifensitrat - tablett - 20 mg

Norvēģija - norvēģu - Statens legemiddelverk

teva b.v. - paracetamol - tablett - 500 mg

Norvēģija - norvēģu - Statens legemiddelverk

xellia pharmaceuticals a. p. s - vankomycinhydroklorid - kapsel, hard - 125 mg

Norvēģija - norvēģu - Statens legemiddelverk

accord healthcare b.v. - darunavirpropylenglykolat - tablett, filmdrasjert - 800 mg

Eiropas Savienība - norvēģu - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.